Cited by 13Schizophrenia research and treatmentMental Health and PsychiatryPsychology and Mental Health

The relationship between insight and subjective experience in schizophrenia

Open access
Kako, Yuki, Ito, Koki, Hashimoto, Naoki, Toyoshima, Kuniyoshi, Shimizu, Yusuke, Mitsui, Nobuyuki, Fujii, Yutaka, Tanaka, Teruaki +1 more·2014·Neuropsychiatric Disease and Treatment

Abstract

OBJECTIVES: To examine the relationship between level of insight and various subjective experiences for patients with schizophrenia. MATERIALS AND METHODS: Seventy-four patients with schizophrenia who were discharged from our hospital were evaluated. The level of insight into their illness and various subjective experiences were evaluated at discharge. We used the Scale to Assess Unawareness of Mental Disorder (SUMD) for evaluation of insight. In addition, five different rating scales were used to evaluate subjective experiences: Subjective Experience of Deficits in Schizophrenia (SEDS), Subjective Well-being under Neuroleptic drug treatment Short form (SWNS), Schizophrenia Quality of Life Scale (SQLS), Beck Depression Inventory (BDI), and the Drug Attitude Inventory (DAI)-30. RESULTS: The SWNS and the scores for awareness of mental disorder and awareness of the social consequences of mental disorder on SUMD showed a weak positive correlation. The DAI-30 showed a significant negative correlation with most general items on SUMD and a negative correlation between the subscale scores for the awareness and attribution of past symptoms. SEDS, SWNS, SQLS, and the BDI significantly correlated with the subscale scores for awareness of current symptoms on SUMD, and weakly correlated with the subscale scores for attribution of current negative symptoms. CONCLUSION: Awareness of subjective distress was related to awareness of having a mental disorder. Feeling subjective distress was related to awareness of current symptoms, as well as to the ability to attribute current negative symptoms to a mental disorder. Positive attitudes toward medication correlated with better general insight into the illness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s66121

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [9]Süllwold L Frankfurter Beschwerde-Fragebogen [Frankfurt Questionnaire of Complaints] 3 Süllwold L Huber G Schizophrene Basisstörungen Berlin Springer 1986 145 159 German
  2. [11]Gross G Huber G Klösterkotter J Linz M Bonner Skala für die Beurteilung von Basissymptomen [Bonn Scale for the Assessment of Basic Symptoms] Berlin Springer 1987 German

Cited by

Sorted by citations

Authors
Kako, Y., Ito, K., Hashimoto, N., Toyoshima, K., Shimizu, Y., Mitsui, N., Fujii, Y., Tanaka, T., & Kusumi, I.
Affiliations
Hokkaido University (JP)
Corresponding author
Kako, Yuki
Venue
Neuropsychiatric Disease and Treatment
Published
2014-07
Volume
10
Pages
1415
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W1982514912
Cited by
13
References
39
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2016: 1 · 2015: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science (18790818)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
  • Social Sciences › Psychology › Clinical Psychology › Psychology and Mental Health
Keywords
schizophrenia, insight into illness, subjective experience, awareness of mental disorder, subjective distress, negative symptoms, attitudes toward drugs, antipsychotic drugs, quality of life, depression, subjective well-being

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review